|
Quintiles Transnational has plenty to CRO about. One of the world's top contract research organizations (CROs), with operations in more than 50 countries, it helps drug and medical device companies develop and sell their products. The firm provides a comprehensive range of clinical trials management services, including patient recruitment, data analysis, laboratory testing, and regulatory filing. Its consulting unit offers strategic advice at every stage of drug discovery and development, and its Innovex subsidiary is a contract sales organization providing sales personnel to promote approved products. An investment group led by founder and CEO Dennis Gillings owns the company.
|
| | | Contact Information | |
Address: |
4820 Emperor Blvd.
Durham, NC 27703
| | Phone: | 919-998-2000 | | Fax: | 919-998-9113 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2007): | 2700.00 M | | Revenue Growth (1 yr): | 6.70% | | Employees (2007): | 21,000 | | Employee Growth (1 yr): | 16.70% |
|
|
Key People
| | • |
Chairman and CEO:
Dennis B. Gillings
| | • |
EVP and CIO:
William R. Deam
| | • |
EVP Corporate Development:
Ronald J. (Ron) Wooten
|
|
|
